Sunshine Biopharma Inc. SBFM
$1.28
+3.23%
at last close
Recent SEC Filings
| Form | Description | Filed | Document |
|---|---|---|---|
| 10-Q | FORM 10-Q FOR JUN 2026 | 2026-08-13 | View → |
| 4 | Insider transaction | 2026-08-11 | View → |
| 8-K | FORM 8-K | 2026-08-03 | View → |
| 424B5 | PROSPECTUS SUPPLEMENT | 2026-07-20 | View → |
| 8-K | FORM 8-K | 2026-07-20 | View → |
| 8-K | CURRENT REPORT | 2026-07-10 | View → |
| 8-K | CURRENT REPORT | 2026-05-29 | View → |
| 8-K | CURRENT REPORT | 2026-05-19 | View → |
| 10-Q | FORM 10-Q FOR MAR 2026 | 2026-05-13 | View → |
| S-1 | FORM S-1 | 2026-05-12 | View → |
| 4 | Insider transaction | 2026-04-14 | View → |
| 8-K | CURRENT REPORT | 2026-04-09 | View → |
| 10-K | FORM 10-K FOR DEC 2025 | 2026-04-03 | View → |
| 8-K | FORM 8-K | 2026-03-09 | View → |
| 8-K | CURRENT REPORT | 2026-02-20 | View → |
| 8-K | CURRENT REPORT | 2026-02-05 | View → |
| 8-K | FORM 8-K | 2025-12-12 | View → |
| 10-Q | FORM 10-Q FOR SEP 2025 | 2025-11-13 | View → |
| DEF 14A | DEFINITIVE PROXY | 2025-10-23 | View → |
| 8-K | CURRENT REPORT | 2025-09-30 | View → |
| 10-Q | FORM 10-Q FOR JUN 2025 | 2025-08-12 | View → |
| S-1 | FORM S-1 | 2025-08-05 | View → |
| 8-K | CURRENT REPORT | 2025-05-19 | View → |
| 10-Q | FORM 10-Q FOR MAR 2025 | 2025-05-15 | View → |
| 8-K | CURRENT REPORT | 2025-04-03 | View → |
| 424B5 | 424B5 | 2025-04-03 | View → |
| 8-K | CURRENT REPORT | 2025-04-02 | View → |
| 10-K | FORM 10-K FOR DEC 2024 | 2025-04-01 | View → |
| 8-K | CURRENT REPORT | 2025-01-15 | View → |
| S-3 | REGISTRATION STATEMENT | 2025-01-06 | View → |
| 8-K | CURRENT REPORT | 2024-12-10 | View → |
| 8-K | FORM 8-K | 2024-11-07 | View → |
| 10-Q | FORM 10-Q FOR SEPT 2024 | 2024-11-05 | View → |
| 8-K | CURRENT REPORT | 2024-10-23 | View → |
| DEF 14A | DEFINITIVE PROXY STATEMENT | 2024-10-17 | View → |
| 8-K | FORM 8-K | 2024-09-10 | View → |
| 8-K | FORM 8-K | 2024-08-19 | View → |
| 10-Q | FORM 10-Q | 2024-08-16 | View → |
| 8-K | FORM 8-K | 2024-08-12 | View → |
| 8-K | FORM 8-K | 2024-07-02 | View → |
Filings are sourced directly from the SEC's EDGAR system. Annual reports (10-K) and quarterly reports (10-Q) carry the full financial statements; 8-K filings disclose material events between reports; Form 4 filings record insider purchases and sales.
Key Stats
- Last Close
- $1.28
- Market Cap
- $4.81 million
- 52-Week Range
- $1.01 – $24.30
- Average Volume
- 951K shs
Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.